Newsroom

Sorted by: Latest

-

GROUPE SEB : DECLARATION MENSUELLE DU NOMBRE D’ACTIONS ET DE DROITS DE VOTE – 31.07.2026

ECULLY, France--(BUSINESS WIRE)--Regulatory News : Groupe SEB (Paris:SK) : Société déclarante Dénomination sociale   SEB S.A Adresse du siège social   112 Chemin du Moulin Carron, 69130 Ecully- France Marché réglementé   Euronext Paris - Compartiment A ISIN   FR0000121709 Nombre d’actions et de droits de vote:   30 juin 2026 31 juillet 2026 Actions composant le capital social (1) 55 337 770 55 337 770 Droits de vote théoriques (2) 79 688 841 79 673 377 Droits de vote exerçables 79 219 067 79 20...
-

Groupe SEB: Monthly Disclosure of the Total Number of Shares and Voting Rights – 31.07.2026

ECULLY, France--(BUSINESS WIRE)--Regulatory News:  Groupe SEB (Paris:SK): Issuer Corporate name   SEB S.A. Registered office   112 Chemin du Moulin Carron, 69130 Ecully- France Stockmarket   Euronext Paris - A ISIN   FR0000121709  Numbers of shares and voting rights :   30 June 2026 31 July 2026 Shares in Euronext (1) 55 337 770 55 337 770 Theoretical voting rights (2) 79 688 841 79 673 377 Effective voting rights 79 219 067 79 209 591 Shares with a par value of 1€ Including voting rights attac...
-

Bowhead Specialty Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Bowhead Specialty Holdings Inc. - BOW

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Bowhead Specialty Holdings Inc. (NYSE: BOW) to American Family Mutual Insurance Company, S.I. Under the terms of the proposed transaction, shareholders of Bowhead will receive $34.00 in cash for each share of Bowhead that they own. KSF is seeking to determine whether this consideration and the proce...
-

Supernus Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Supernus Pharmaceuticals, Inc. - SUPN

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Supernus Pharmaceuticals, Inc. (NasdaqGM: SUPN) to Indivior Pharmaceuticals, Inc. (Nasdaq: INDV). Under the terms of the proposed transaction, shareholders of Supernus will receive 1.5401 common shares of Indivior for each share of Supernus that they own. KSF is seeking to determine whether this con...
-

Integer Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Integer Holdings Corporation - ITGR

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Integer Holdings Corporation (NYSE: ITGR) to KKR. Under the terms of the proposed transaction, shareholders of Integer will receive $127.00 in cash for each share of Integer that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether...
-

Weiss Asset Management LP UK Regulatory Announcement: Form 8.3 - Amendment

BOSTON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)* *This is a restatement of the previously filed Form 8.3, including an amended price which was incorrect due to an administrative error. 1. KEY INFORMATION (a) Full name of discloser: Weiss Asset Management LP (Investment Manager of Brookdale International Partners, L.P. and Brookdale Global...
-

Atkore Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Atkore Inc. - ATKR

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Atkore Inc. (NYSE: ATKR) to Prysmian S.p.A. Under the terms of the proposed transaction, shareholders of Atkore will receive $95.00 in cash for each share of Atkore that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the...
-

Laserficheتُطلق نظام Enterprise Security المتطور لتوفير استعادة البيانات في حالات الكوارث متعددة المناطق والامتثال لمعايير GovRAMP للقطاعات الشديدة التنظيم

لونغ بيتش، كاليفورنيا--(BUSINESS WIRE)--اليوم، أعلنت Laserfiche، الرائدة في مجال توفير حلول إدارة المحتوى الذكية عبر البرمجيات كخدمة (SaaS) عن إطلاق Enterprise Security، وهي مجموعة متقدمة من التحسينات الأمنية المصممة للمؤسسات التي تتعامل مع بيئات تنظيمية معقدة. تغطي Enterprise Security متطلبات الأمن الخاصة التي ينص عليها كل من GovRAMP وCJIS (خدمات معلومات العدالة الجنائية) استنادًا إلى إطار العمل NIST SP 800-53. وبالنسبة للمؤسسات التي تتعامل مع بيانات المواطنين أو البيانات القانونية أو بيانات ال...
-

Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Lantheus Holdings, Inc. (NasdaqGM: LNTH) to Curium US Holdings LLC. Under the terms of the proposed transaction, shareholders of Lantheus will receive $102.50 per share in cash, plus non-transferable Contingent Value Rights providing for up to $12.00 per share in potential additional cash payments,...
-

Charles Schwab Investment Management, Inc. UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Charles Schwab Investment Management, Inc. (CSIM) in its capacity as investment advisor to clients. CSIM expressly disclaims beneficial ownership of the shares described in this form 8.3. (b) Owner or controller of interests and short positions...